Related references
Note: Only part of the references are listed.Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity
Fotios Barkas et al.
JOURNAL OF CARDIOLOGY (2019)
Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study
Matina Kouvari et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Metabolically healthy versus metabolically unhealthy obesity
Carla Iacobini et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver
Ki-Chul Sung et al.
ATHEROSCLEROSIS (2018)
Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women
Rishi Caleyachetty et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Metabolically Healthy Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study
Masanari Kuwabara et al.
OBESITY (2017)
Impact of physical activity on the association of overweight and obesity with cardiovascular disease: The Rotterdam Study
Chantal M. Koolhaas et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials)
Payal Kohli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Statin therapy with or without ezetimibe and the progression to diabetes
Fotios Barkas et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity
Chang Hee Jung et al.
OBESITY (2016)
Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes
Antonio J. Vallejo-Vaz et al.
ATHEROSCLEROSIS (2015)
Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study
Guy-Marino Hinnouho et al.
EUROPEAN HEART JOURNAL (2015)
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Share Paper
